| 93.56 Delayed Data As of Jul 19 |  -0.70 / -0.74%Today’s Change | 72.63 Today|||52-Week Range 95.00 | +21.73% Year-to-Date |
| Previous close | 94.26 |
| Today’s open | 94.80 |
| Day’s range | 93.37 - 94.87 |
| Volume | 3,484,360 |
| Average volume (3 months) | 2,442,656 |
| Market cap | $214.8B |
| Earnings growth (last year) | +65.34% |
| Earnings growth (this year) | +9.97% |
| Earnings growth (next 5 years) | +8.70% |
| Revenue growth (last year) | +5.41% |
| P/E ratio | 31.7 |
| Price/Sales | 3.87 |
| Price/Book | 2.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -1.30 | -1.57% |
| PFEPfizer | -0.29 | -0.67% |
| AZNAstraZeneca | -0.61 | -1.50% |
| SNYSanofi | 0.00 | 0.00% |
| Next reporting date | October 22, 2019 |
| EPS forecast (this quarter) | $1.29 |
| Annual revenue (last year) | $52.0B |
| Annual profit (last year) | $12.6B |
| Net profit margin | 24.30% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer Vasant Narasimhan |
Chief Financial Officer Harry Werner Kirsch |
Corporate headquarters Basel, Basel-stadt (basle Town) |
